Cargando…

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Bayer, Michael, Wang, Xiaojin, Chen, Chengwei, Chen, Xiaosong, Fu, Qingchun, He, Jia, Cao, William, Fredrickson, Craig, Cannon, Jessica, Cornforth, Andrew, Nistor, Gabriel, Dillman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288648/
http://dx.doi.org/10.1186/2051-1426-2-S3-P44
_version_ 1782352002550857728
author Bayer, Michael
Wang, Xiaojin
Chen, Chengwei
Chen, Xiaosong
Fu, Qingchun
He, Jia
Cao, William
Fredrickson, Craig
Cannon, Jessica
Cornforth, Andrew
Nistor, Gabriel
Dillman, Robert
author_facet Bayer, Michael
Wang, Xiaojin
Chen, Chengwei
Chen, Xiaosong
Fu, Qingchun
He, Jia
Cao, William
Fredrickson, Craig
Cannon, Jessica
Cornforth, Andrew
Nistor, Gabriel
Dillman, Robert
author_sort Bayer, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-4288648
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42886482015-01-15 Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma Bayer, Michael Wang, Xiaojin Chen, Chengwei Chen, Xiaosong Fu, Qingchun He, Jia Cao, William Fredrickson, Craig Cannon, Jessica Cornforth, Andrew Nistor, Gabriel Dillman, Robert J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288648/ http://dx.doi.org/10.1186/2051-1426-2-S3-P44 Text en Copyright © 2014 Bayer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Bayer, Michael
Wang, Xiaojin
Chen, Chengwei
Chen, Xiaosong
Fu, Qingchun
He, Jia
Cao, William
Fredrickson, Craig
Cannon, Jessica
Cornforth, Andrew
Nistor, Gabriel
Dillman, Robert
Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title_full Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title_fullStr Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title_full_unstemmed Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title_short Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
title_sort phase i trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis b positive patients with hepatocellular carcinoma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288648/
http://dx.doi.org/10.1186/2051-1426-2-S3-P44
work_keys_str_mv AT bayermichael phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT wangxiaojin phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT chenchengwei phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT chenxiaosong phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT fuqingchun phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT hejia phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT caowilliam phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT fredricksoncraig phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT cannonjessica phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT cornforthandrew phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT nistorgabriel phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma
AT dillmanrobert phaseitrialofactivespecificimmunotherapywithautologousdendriticcellspulsedwithautologousirradiatedtumorstemcellsinhepatitisbpositivepatientswithhepatocellularcarcinoma